

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.42355657 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.42355657 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.11732805 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.11732805 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 5.91825837 |
| 6 | cysteine metabolic process (GO:0006534) | 5.59347076 |
| 7 | tryptophan catabolic process (GO:0006569) | 5.47955335 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 5.47955335 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 5.47955335 |
| 10 | tryptophan metabolic process (GO:0006568) | 5.34688413 |
| 11 | serine family amino acid catabolic process (GO:0009071) | 5.15738708 |
| 12 | lysine metabolic process (GO:0006553) | 5.11460672 |
| 13 | lysine catabolic process (GO:0006554) | 5.11460672 |
| 14 | kynurenine metabolic process (GO:0070189) | 5.06023674 |
| 15 | glyoxylate metabolic process (GO:0046487) | 5.04080914 |
| 16 | homocysteine metabolic process (GO:0050667) | 4.85615356 |
| 17 | drug transmembrane transport (GO:0006855) | 4.78379409 |
| 18 | urate metabolic process (GO:0046415) | 4.63639186 |
| 19 | aromatic amino acid family metabolic process (GO:0009072) | 4.50776956 |
| 20 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.45351615 |
| 21 | amino-acid betaine metabolic process (GO:0006577) | 4.44766427 |
| 22 | bile acid biosynthetic process (GO:0006699) | 4.41497341 |
| 23 | indolalkylamine metabolic process (GO:0006586) | 4.29934905 |
| 24 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.27916695 |
| 25 | protein carboxylation (GO:0018214) | 4.21211664 |
| 26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.21211664 |
| 27 | alpha-amino acid catabolic process (GO:1901606) | 4.19920847 |
| 28 | serine family amino acid metabolic process (GO:0009069) | 4.17755607 |
| 29 | sulfur amino acid catabolic process (GO:0000098) | 4.15242748 |
| 30 | glutamate metabolic process (GO:0006536) | 4.02548021 |
| 31 | glycine metabolic process (GO:0006544) | 4.02507006 |
| 32 | cellular ketone body metabolic process (GO:0046950) | 3.99581148 |
| 33 | cellular biogenic amine catabolic process (GO:0042402) | 3.98585128 |
| 34 | amine catabolic process (GO:0009310) | 3.98585128 |
| 35 | valine metabolic process (GO:0006573) | 3.97353554 |
| 36 | 2-oxoglutarate metabolic process (GO:0006103) | 3.95799668 |
| 37 | tyrosine metabolic process (GO:0006570) | 3.95449207 |
| 38 | urea cycle (GO:0000050) | 3.93244291 |
| 39 | urea metabolic process (GO:0019627) | 3.93244291 |
| 40 | cellular amino acid catabolic process (GO:0009063) | 3.92765307 |
| 41 | short-chain fatty acid metabolic process (GO:0046459) | 3.92393068 |
| 42 | regulation of cholesterol homeostasis (GO:2000188) | 3.91512836 |
| 43 | bile acid metabolic process (GO:0008206) | 3.90581656 |
| 44 | nitrogen cycle metabolic process (GO:0071941) | 3.82825786 |
| 45 | glucuronate metabolic process (GO:0019585) | 3.82432555 |
| 46 | uronic acid metabolic process (GO:0006063) | 3.82432555 |
| 47 | drug transport (GO:0015893) | 3.81812854 |
| 48 | respiratory chain complex IV assembly (GO:0008535) | 3.78910803 |
| 49 | cellular glucuronidation (GO:0052695) | 3.78821413 |
| 50 | aldehyde catabolic process (GO:0046185) | 3.77050069 |
| 51 | alpha-linolenic acid metabolic process (GO:0036109) | 3.76841628 |
| 52 | drug catabolic process (GO:0042737) | 3.74203332 |
| 53 | acylglycerol homeostasis (GO:0055090) | 3.73499860 |
| 54 | triglyceride homeostasis (GO:0070328) | 3.73499860 |
| 55 | complement activation, alternative pathway (GO:0006957) | 3.72620488 |
| 56 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.72349827 |
| 57 | vitamin transmembrane transport (GO:0035461) | 3.71153890 |
| 58 | fructose metabolic process (GO:0006000) | 3.70972701 |
| 59 | regulation of protein activation cascade (GO:2000257) | 3.70714990 |
| 60 | regulation of triglyceride catabolic process (GO:0010896) | 3.68223435 |
| 61 | regulation of bile acid biosynthetic process (GO:0070857) | 3.63932127 |
| 62 | aspartate family amino acid catabolic process (GO:0009068) | 3.61871712 |
| 63 | negative regulation of fibrinolysis (GO:0051918) | 3.60350229 |
| 64 | high-density lipoprotein particle remodeling (GO:0034375) | 3.55016573 |
| 65 | fatty acid oxidation (GO:0019395) | 3.54673170 |
| 66 | fatty acid beta-oxidation (GO:0006635) | 3.53939542 |
| 67 | bile acid and bile salt transport (GO:0015721) | 3.53741724 |
| 68 | organic acid catabolic process (GO:0016054) | 3.53330467 |
| 69 | carboxylic acid catabolic process (GO:0046395) | 3.53330467 |
| 70 | amino acid salvage (GO:0043102) | 3.51146828 |
| 71 | L-methionine salvage (GO:0071267) | 3.51146828 |
| 72 | L-methionine biosynthetic process (GO:0071265) | 3.51146828 |
| 73 | carnitine metabolic process (GO:0009437) | 3.49996424 |
| 74 | regulation of complement activation (GO:0030449) | 3.48385460 |
| 75 | acetyl-CoA metabolic process (GO:0006084) | 3.47465147 |
| 76 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.47198101 |
| 77 | ketone body metabolic process (GO:1902224) | 3.47111642 |
| 78 | lipid oxidation (GO:0034440) | 3.46395865 |
| 79 | imidazole-containing compound metabolic process (GO:0052803) | 3.44995144 |
| 80 | cytochrome complex assembly (GO:0017004) | 3.42579484 |
| 81 | cellular modified amino acid catabolic process (GO:0042219) | 3.42373512 |
| 82 | fatty acid catabolic process (GO:0009062) | 3.41317945 |
| 83 | coenzyme catabolic process (GO:0009109) | 3.39625989 |
| 84 | benzene-containing compound metabolic process (GO:0042537) | 3.38492936 |
| 85 | regulation of fibrinolysis (GO:0051917) | 3.37040329 |
| 86 | immunoglobulin mediated immune response (GO:0016064) | 3.35782319 |
| 87 | DNA deamination (GO:0045006) | 3.35102465 |
| 88 | monocarboxylic acid catabolic process (GO:0072329) | 3.35019543 |
| 89 | serine family amino acid biosynthetic process (GO:0009070) | 3.35006466 |
| 90 | biotin metabolic process (GO:0006768) | 3.33435780 |
| 91 | branched-chain amino acid metabolic process (GO:0009081) | 3.32621301 |
| 92 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 3.32462808 |
| 93 | branched-chain amino acid catabolic process (GO:0009083) | 3.31789416 |
| 94 | exogenous drug catabolic process (GO:0042738) | 3.31541012 |
| 95 | response to mercury ion (GO:0046689) | 3.29598064 |
| 96 | indole-containing compound metabolic process (GO:0042430) | 3.28193187 |
| 97 | plasma lipoprotein particle clearance (GO:0034381) | 3.22799400 |
| 98 | ethanol oxidation (GO:0006069) | 3.22560732 |
| 99 | NADH metabolic process (GO:0006734) | 3.21692628 |
| 100 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.20741611 |
| 101 | phospholipid homeostasis (GO:0055091) | 3.14080617 |
| 102 | cullin deneddylation (GO:0010388) | 3.13278832 |
| 103 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 3.13072562 |
| 104 | pantothenate metabolic process (GO:0015939) | 3.09736650 |
| 105 | protein deneddylation (GO:0000338) | 3.09103656 |
| 106 | B cell mediated immunity (GO:0019724) | 3.08924096 |
| 107 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.06954326 |
| 108 | tricarboxylic acid cycle (GO:0006099) | 3.06176897 |
| 109 | sulfur amino acid metabolic process (GO:0000096) | 3.05174240 |
| 110 | reverse cholesterol transport (GO:0043691) | 3.05105913 |
| 111 | proteasome assembly (GO:0043248) | 3.04827906 |
| 112 | small molecule catabolic process (GO:0044282) | 3.04073730 |
| 113 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.02850273 |
| 114 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.01851560 |
| 115 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.01851560 |
| 116 | response to nitrosative stress (GO:0051409) | 2.99164313 |
| 117 | macroautophagy (GO:0016236) | 2.97763429 |
| 118 | oxidative phosphorylation (GO:0006119) | 2.95026205 |
| 119 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.92337317 |
| 120 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.92144097 |
| 121 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.91865409 |
| 122 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.90515503 |
| 123 | cytidine catabolic process (GO:0006216) | 2.88778271 |
| 124 | cytidine deamination (GO:0009972) | 2.88778271 |
| 125 | cytidine metabolic process (GO:0046087) | 2.88778271 |
| 126 | oxaloacetate metabolic process (GO:0006107) | 2.86302573 |
| 127 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.84459222 |
| 128 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.81886237 |
| 129 | methionine biosynthetic process (GO:0009086) | 2.80994814 |
| 130 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.79435649 |
| 131 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.75252373 |
| 132 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.72924547 |
| 133 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.72924547 |
| 134 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.72924547 |
| 135 | succinate metabolic process (GO:0006105) | 2.72921745 |
| 136 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.72577598 |
| 137 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.72577598 |
| 138 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.70631989 |
| 139 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.66476883 |
| 140 | protein complex biogenesis (GO:0070271) | 2.65643755 |
| 141 | vitamin biosynthetic process (GO:0009110) | 2.65224839 |
| 142 | quinone biosynthetic process (GO:1901663) | 2.64456668 |
| 143 | xenobiotic catabolic process (GO:0042178) | 2.64324134 |
| 144 | DNA double-strand break processing (GO:0000729) | 2.63269345 |
| 145 | S-adenosylmethionine metabolic process (GO:0046500) | 2.61038760 |
| 146 | methionine metabolic process (GO:0006555) | 2.60472684 |
| 147 | negative regulation of ligase activity (GO:0051352) | 2.59194400 |
| 148 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.59194400 |
| 149 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.58919449 |
| 150 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.58919449 |
| 151 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.58603551 |
| 152 | positive regulation of B cell differentiation (GO:0045579) | 2.58108645 |
| 153 | purine nucleobase biosynthetic process (GO:0009113) | 2.57755701 |
| 154 | iron-sulfur cluster assembly (GO:0016226) | 2.57642305 |
| 155 | metallo-sulfur cluster assembly (GO:0031163) | 2.57642305 |
| 156 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.56962346 |
| 157 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.56962346 |
| 158 | purine deoxyribonucleotide metabolic process (GO:0009151) | 2.55774282 |
| 159 | regulation of B cell apoptotic process (GO:0002902) | 2.55236508 |
| 160 | adenosine metabolic process (GO:0046085) | 2.54277859 |
| 161 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.51861497 |
| 162 | ubiquinone biosynthetic process (GO:0006744) | 2.48765823 |
| 163 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.46783142 |
| 164 | protein neddylation (GO:0045116) | 2.46724007 |
| 165 | regulation of mitochondrial translation (GO:0070129) | 2.46502839 |
| 166 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.45990456 |
| 167 | aerobic respiration (GO:0009060) | 2.45192721 |
| 168 | deoxyribose phosphate catabolic process (GO:0046386) | 2.41931251 |
| 169 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.40965209 |
| 170 | DNA ligation (GO:0006266) | 2.39867532 |
| 171 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.39496776 |
| 172 | deoxyribonucleotide catabolic process (GO:0009264) | 2.35895931 |
| 173 | positive regulation of ligase activity (GO:0051351) | 2.31188461 |
| 174 | nucleobase biosynthetic process (GO:0046112) | 2.30671081 |
| 175 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.30646367 |
| 176 | regulation of cellular amine metabolic process (GO:0033238) | 2.29627483 |
| 177 | aspartate family amino acid biosynthetic process (GO:0009067) | 2.29096142 |
| 178 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.28343136 |
| 179 | protein maturation by protein folding (GO:0022417) | 2.27548264 |
| 180 | L-fucose catabolic process (GO:0042355) | 2.26545258 |
| 181 | fucose catabolic process (GO:0019317) | 2.26545258 |
| 182 | L-fucose metabolic process (GO:0042354) | 2.26545258 |
| 183 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.25706629 |
| 184 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.25569657 |
| 185 | pseudouridine synthesis (GO:0001522) | 2.24912731 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.82009533 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.06663682 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.01547367 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.59497496 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.59273473 |
| 6 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.62141002 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.35803163 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.01332537 |
| 9 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.88871717 |
| 10 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.72842587 |
| 11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.72489718 |
| 12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.52866634 |
| 13 | GATA1_22025678_ChIP-Seq_K562_Human | 3.29566226 |
| 14 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.20413316 |
| 15 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.20330093 |
| 16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.02562386 |
| 17 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.79453519 |
| 18 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.72985849 |
| 19 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.41792552 |
| 20 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.38023777 |
| 21 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.31885831 |
| 22 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.25023626 |
| 23 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.24606476 |
| 24 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.21091226 |
| 25 | * CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.19900764 |
| 26 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.19329179 |
| 27 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.18245131 |
| 28 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.15679972 |
| 29 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.08308748 |
| 30 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.98294136 |
| 31 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.97681892 |
| 32 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.96096769 |
| 33 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.95949392 |
| 34 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.93109943 |
| 35 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.89062894 |
| 36 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.86019044 |
| 37 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.85489567 |
| 38 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.85009999 |
| 39 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.82280313 |
| 40 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.80611156 |
| 41 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.80426702 |
| 42 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80205367 |
| 43 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.78532285 |
| 44 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.74939148 |
| 45 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.71829636 |
| 46 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.67720817 |
| 47 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.67351270 |
| 48 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.65187023 |
| 49 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.60605324 |
| 50 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.54235284 |
| 51 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.50226501 |
| 52 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.47483517 |
| 53 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.43299684 |
| 54 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.40953579 |
| 55 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.40638496 |
| 56 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.39218687 |
| 57 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.38880881 |
| 58 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.38697524 |
| 59 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.38697524 |
| 60 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.38045479 |
| 61 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37543637 |
| 62 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.34504489 |
| 63 | MYB_26560356_Chip-Seq_TH2_Human | 1.34160415 |
| 64 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.34135421 |
| 65 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.31690912 |
| 66 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.30197314 |
| 67 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.27501168 |
| 68 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.24164121 |
| 69 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.24004386 |
| 70 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.22526392 |
| 71 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.22296165 |
| 72 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.21824799 |
| 73 | GATA3_26560356_Chip-Seq_TH2_Human | 1.20678247 |
| 74 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.19979750 |
| 75 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.19589367 |
| 76 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.19434785 |
| 77 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.17945084 |
| 78 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.14881781 |
| 79 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.13629834 |
| 80 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.13625840 |
| 81 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.13250383 |
| 82 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.12657587 |
| 83 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.12482357 |
| 84 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.12472169 |
| 85 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.11632015 |
| 86 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.10484790 |
| 87 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.06613253 |
| 88 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06079087 |
| 89 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.04899501 |
| 90 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.04520765 |
| 91 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.04379355 |
| 92 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.04351773 |
| 93 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.04343111 |
| 94 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.04268446 |
| 95 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03191470 |
| 96 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.01184592 |
| 97 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.98238337 |
| 98 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.97488935 |
| 99 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.97280203 |
| 100 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.96553916 |
| 101 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.96001964 |
| 102 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.94617605 |
| 103 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.94375298 |
| 104 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.91852319 |
| 105 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.89578364 |
| 106 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.88441937 |
| 107 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.88103168 |
| 108 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87822411 |
| 109 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.87250907 |
| 110 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.87077571 |
| 111 | * EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.87018277 |
| 112 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.86589799 |
| 113 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.86404271 |
| 114 | * MYB_26560356_Chip-Seq_TH1_Human | 0.85153643 |
| 115 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.83688913 |
| 116 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.82846361 |
| 117 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.81843834 |
| 118 | CBP_21632823_ChIP-Seq_H3396_Human | 0.81279674 |
| 119 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.81049298 |
| 120 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.80855880 |
| 121 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.80853572 |
| 122 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.80689930 |
| 123 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.80652089 |
| 124 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.79995161 |
| 125 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.79971505 |
| 126 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.79296662 |
| 127 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.76699943 |
| 128 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.75288727 |
| 129 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.74108375 |
| 130 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.71060186 |
| 131 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.70496872 |
| 132 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.69975962 |
| 133 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.69789926 |
| 134 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.69321209 |
| 135 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.68241452 |
| 136 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.67996263 |
| 137 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.66332074 |
| 138 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.66130304 |
| 139 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.63353664 |
| 140 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.62842252 |
| 141 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.62567129 |
| 142 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.62321223 |
| 143 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.62288088 |
| 144 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.61357726 |
| 145 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.61082684 |
| 146 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.60607313 |
| 147 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.59632782 |
| 148 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.59571235 |
| 149 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.58837358 |
| 150 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.58648210 |
| 151 | AR_20517297_ChIP-Seq_VCAP_Human | 0.58515092 |
| 152 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.58373390 |
| 153 | GATA1_19941826_ChIP-Seq_K562_Human | 0.57528307 |
| 154 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.57317792 |
| 155 | RXR_22108803_ChIP-Seq_LS180_Human | 0.57090356 |
| 156 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.56589462 |
| 157 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.56385048 |
| 158 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.55560431 |
| 159 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.55030885 |
| 160 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.54235532 |
| 161 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.53779667 |
| 162 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.53664761 |
| 163 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.53625238 |
| 164 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.53377636 |
| 165 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.52972845 |
| 166 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.52945532 |
| 167 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.51732367 |
| 168 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.51122055 |
| 169 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.50842368 |
| 170 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.50694105 |
| 171 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.50655526 |
| 172 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.50577947 |
| 173 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.48519636 |
| 174 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.48462365 |
| 175 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.48430081 |
| 176 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.47476814 |
| 177 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.46519731 |
| 178 | GATA2_19941826_ChIP-Seq_K562_Human | 0.44994218 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.32585991 |
| 2 | MP0005360_urolithiasis | 6.60782543 |
| 3 | MP0005365_abnormal_bile_salt | 5.04947226 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.03473686 |
| 5 | MP0003195_calcinosis | 4.29107089 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.08558196 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.80631755 |
| 8 | MP0003252_abnormal_bile_duct | 3.62309122 |
| 9 | MP0005332_abnormal_amino_acid | 3.34947367 |
| 10 | MP0010329_abnormal_lipoprotein_level | 2.82003428 |
| 11 | MP0004019_abnormal_vitamin_homeostasis | 2.77753346 |
| 12 | MP0009840_abnormal_foam_cell | 2.70817473 |
| 13 | MP0004043_abnormal_pH_regulation | 2.63199552 |
| 14 | MP0001835_abnormal_antigen_presentation | 2.51339634 |
| 15 | MP0002138_abnormal_hepatobiliary_system | 2.27469538 |
| 16 | MP0005075_abnormal_melanosome_morpholog | 2.27289209 |
| 17 | MP0001666_abnormal_nutrient_absorption | 2.18514930 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 2.17854874 |
| 19 | MP0002118_abnormal_lipid_homeostasis | 2.07676545 |
| 20 | MP0009643_abnormal_urine_homeostasis | 2.05901733 |
| 21 | MP0004147_increased_porphyrin_level | 1.92324077 |
| 22 | MP0000609_abnormal_liver_physiology | 1.91468263 |
| 23 | MP0009785_altered_susceptibility_to | 1.90615336 |
| 24 | MP0005083_abnormal_biliary_tract | 1.86256602 |
| 25 | MP0005451_abnormal_body_composition | 1.83957220 |
| 26 | MP0005319_abnormal_enzyme/_coenzyme | 1.78215090 |
| 27 | MP0005058_abnormal_lysosome_morphology | 1.74351515 |
| 28 | MP0003183_abnormal_peptide_metabolism | 1.71198472 |
| 29 | MP0003868_abnormal_feces_composition | 1.65952161 |
| 30 | MP0010234_abnormal_vibrissa_follicle | 1.65711574 |
| 31 | MP0002166_altered_tumor_susceptibility | 1.61900804 |
| 32 | MP0002876_abnormal_thyroid_physiology | 1.61754253 |
| 33 | MP0005636_abnormal_mineral_homeostasis | 1.60408005 |
| 34 | MP0002148_abnormal_hypersensitivity_rea | 1.53916390 |
| 35 | MP0010094_abnormal_chromosome_stability | 1.53404839 |
| 36 | MP0001756_abnormal_urination | 1.53158024 |
| 37 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.52559709 |
| 38 | MP0001764_abnormal_homeostasis | 1.51108552 |
| 39 | MP0001765_abnormal_ion_homeostasis | 1.50540131 |
| 40 | MP0005670_abnormal_white_adipose | 1.50378361 |
| 41 | MP0001800_abnormal_humoral_immune | 1.40792729 |
| 42 | MP0005025_abnormal_response_to | 1.38728685 |
| 43 | MP0003303_peritoneal_inflammation | 1.37552358 |
| 44 | MP0002419_abnormal_innate_immunity | 1.36705675 |
| 45 | MP0005671_abnormal_response_to | 1.35726437 |
| 46 | MP0009333_abnormal_splenocyte_physiolog | 1.33519834 |
| 47 | MP0003186_abnormal_redox_activity | 1.33428483 |
| 48 | MP0002078_abnormal_glucose_homeostasis | 1.32768201 |
| 49 | MP0003693_abnormal_embryo_hatching | 1.31519315 |
| 50 | MP0006054_spinal_hemorrhage | 1.31203605 |
| 51 | MP0005000_abnormal_immune_tolerance | 1.30610752 |
| 52 | MP0008058_abnormal_DNA_repair | 1.29119310 |
| 53 | MP0006082_CNS_inflammation | 1.28196386 |
| 54 | MP0004130_abnormal_muscle_cell | 1.25372245 |
| 55 | MP0002452_abnormal_antigen_presenting | 1.25089049 |
| 56 | MP0008260_abnormal_autophagy | 1.22458324 |
| 57 | MP0006036_abnormal_mitochondrial_physio | 1.22059502 |
| 58 | MP0002006_tumorigenesis | 1.21287822 |
| 59 | MP0003075_altered_response_to | 1.20996642 |
| 60 | MP0000015_abnormal_ear_pigmentation | 1.19316224 |
| 61 | MP0002723_abnormal_immune_serum | 1.18160197 |
| 62 | MP0003763_abnormal_thymus_physiology | 1.17418124 |
| 63 | MP0005084_abnormal_gallbladder_morpholo | 1.17091870 |
| 64 | MP0002420_abnormal_adaptive_immunity | 1.16574601 |
| 65 | MP0001819_abnormal_immune_cell | 1.14997558 |
| 66 | MP0001790_abnormal_immune_system | 1.14943990 |
| 67 | MP0005387_immune_system_phenotype | 1.14943990 |
| 68 | MP0009764_decreased_sensitivity_to | 1.13540273 |
| 69 | MP0010155_abnormal_intestine_physiology | 1.12899054 |
| 70 | MP0000465_gastrointestinal_hemorrhage | 1.12555486 |
| 71 | MP0000689_abnormal_spleen_morphology | 1.12420102 |
| 72 | MP0008007_abnormal_cellular_replicative | 1.11006756 |
| 73 | MP0002136_abnormal_kidney_physiology | 1.10519450 |
| 74 | MP0005220_abnormal_exocrine_pancreas | 1.09944318 |
| 75 | MP0005165_increased_susceptibility_to | 1.08289786 |
| 76 | MP0001661_extended_life_span | 1.04774934 |
| 77 | MP0000013_abnormal_adipose_tissue | 1.04018621 |
| 78 | MP0008872_abnormal_physiological_respon | 1.03688606 |
| 79 | MP0005535_abnormal_body_temperature | 1.03195737 |
| 80 | MP0002132_abnormal_respiratory_system | 1.02389691 |
| 81 | MP0002837_dystrophic_cardiac_calcinosis | 1.02278098 |
| 82 | MP0002928_abnormal_bile_duct | 1.01173793 |
| 83 | MP0003786_premature_aging | 1.00315903 |
| 84 | MP0003724_increased_susceptibility_to | 0.99153932 |
| 85 | MP0000604_amyloidosis | 0.98073869 |
| 86 | MP0009642_abnormal_blood_homeostasis | 0.97696247 |
| 87 | MP0003172_abnormal_lysosome_physiology | 0.97656685 |
| 88 | MP0003866_abnormal_defecation | 0.96210534 |
| 89 | MP0000598_abnormal_liver_morphology | 0.96046031 |
| 90 | MP0005645_abnormal_hypothalamus_physiol | 0.95457852 |
| 91 | MP0002693_abnormal_pancreas_physiology | 0.95300742 |
| 92 | MP0002398_abnormal_bone_marrow | 0.93646705 |
| 93 | MP0000716_abnormal_immune_system | 0.93348218 |
| 94 | MP0001944_abnormal_pancreas_morphology | 0.93039374 |
| 95 | MP0004215_abnormal_myocardial_fiber | 0.91619297 |
| 96 | MP0008469_abnormal_protein_level | 0.91089528 |
| 97 | MP0009763_increased_sensitivity_to | 0.88204631 |
| 98 | MP0000230_abnormal_systemic_arterial | 0.87906806 |
| 99 | MP0002722_abnormal_immune_system | 0.87723794 |
| 100 | MP0003690_abnormal_glial_cell | 0.85584951 |
| 101 | MP0000685_abnormal_immune_system | 0.85548082 |
| 102 | MP0005666_abnormal_adipose_tissue | 0.85406510 |
| 103 | MP0003329_amyloid_beta_deposits | 0.84917865 |
| 104 | MP0006035_abnormal_mitochondrial_morpho | 0.84007780 |
| 105 | MP0002429_abnormal_blood_cell | 0.82608671 |
| 106 | MP0003953_abnormal_hormone_level | 0.81158967 |
| 107 | MP0002971_abnormal_brown_adipose | 0.81059600 |
| 108 | MP0008057_abnormal_DNA_replication | 0.80601914 |
| 109 | MP0005334_abnormal_fat_pad | 0.77602208 |
| 110 | MP0001853_heart_inflammation | 0.76546714 |
| 111 | MP0000747_muscle_weakness | 0.74919648 |
| 112 | MP0002877_abnormal_melanocyte_morpholog | 0.74479536 |
| 113 | MP0004957_abnormal_blastocyst_morpholog | 0.74474437 |
| 114 | MP0000678_abnormal_parathyroid_gland | 0.73537824 |
| 115 | MP0005395_other_phenotype | 0.71526277 |
| 116 | MP0002168_other_aberrant_phenotype | 0.71003319 |
| 117 | MP0009765_abnormal_xenobiotic_induced | 0.70746556 |
| 118 | MP0008961_abnormal_basal_metabolism | 0.70148079 |
| 119 | MP0005647_abnormal_sex_gland | 0.69320268 |
| 120 | MP0005375_adipose_tissue_phenotype | 0.69293652 |
| 121 | MP0009780_abnormal_chondrocyte_physiolo | 0.67965142 |
| 122 | MP0005376_homeostasis/metabolism_phenot | 0.66812120 |
| 123 | MP0005448_abnormal_energy_balance | 0.66775283 |
| 124 | MP0003656_abnormal_erythrocyte_physiolo | 0.62329615 |
| 125 | MP0000003_abnormal_adipose_tissue | 0.60173317 |
| 126 | MP0005266_abnormal_metabolism | 0.60155772 |
| 127 | MP0003718_maternal_effect | 0.58743385 |
| 128 | MP0002909_abnormal_adrenal_gland | 0.58685577 |
| 129 | MP0010386_abnormal_urinary_bladder | 0.56630254 |
| 130 | MP0003959_abnormal_lean_body | 0.55567067 |
| 131 | MP0003879_abnormal_hair_cell | 0.54455718 |
| 132 | MP0009697_abnormal_copulation | 0.54106739 |
| 133 | MP0005330_cardiomyopathy | 0.50011414 |
| 134 | MP0002822_catalepsy | 0.48677693 |
| 135 | MP0005379_endocrine/exocrine_gland_phen | 0.48513826 |
| 136 | MP0005166_decreased_susceptibility_to | 0.48495962 |
| 137 | MP0002896_abnormal_bone_mineralization | 0.47774507 |
| 138 | MP0002269_muscular_atrophy | 0.46942681 |
| 139 | MP0003638_abnormal_response/metabolism_ | 0.45749694 |
| 140 | MP0001881_abnormal_mammary_gland | 0.43665583 |
| 141 | MP0000920_abnormal_myelination | 0.43646969 |
| 142 | MP0008874_decreased_physiological_sensi | 0.42926055 |
| 143 | MP0003221_abnormal_cardiomyocyte_apopto | 0.42558695 |
| 144 | MP0004264_abnormal_extraembryonic_tissu | 0.42473723 |
| 145 | MP0003436_decreased_susceptibility_to | 0.41907147 |
| 146 | MP0005408_hypopigmentation | 0.41866988 |
| 147 | MP0001502_abnormal_circadian_rhythm | 0.41351138 |
| 148 | MP0001845_abnormal_inflammatory_respons | 0.41029191 |
| 149 | MP0005464_abnormal_platelet_physiology | 0.40380120 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.69474161 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 5.30719629 |
| 3 | Hyperglycinuria (HP:0003108) | 5.03455853 |
| 4 | Hyperglycinemia (HP:0002154) | 4.84590738 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.73382713 |
| 6 | Gout (HP:0001997) | 4.63912936 |
| 7 | Xanthomatosis (HP:0000991) | 4.54396624 |
| 8 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.51554375 |
| 9 | Abnormality of glycine metabolism (HP:0010895) | 4.51554375 |
| 10 | Hypoglycemic coma (HP:0001325) | 4.32387310 |
| 11 | Prolonged partial thromboplastin time (HP:0003645) | 4.29447963 |
| 12 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.23271888 |
| 13 | Ketosis (HP:0001946) | 4.02131249 |
| 14 | Deep venous thrombosis (HP:0002625) | 4.00071644 |
| 15 | Generalized aminoaciduria (HP:0002909) | 3.88573454 |
| 16 | Hyperlipoproteinemia (HP:0010980) | 3.85799307 |
| 17 | Ketoacidosis (HP:0001993) | 3.78526053 |
| 18 | Microvesicular hepatic steatosis (HP:0001414) | 3.74758265 |
| 19 | Conjugated hyperbilirubinemia (HP:0002908) | 3.68025929 |
| 20 | Abnormality of purine metabolism (HP:0004352) | 3.62402773 |
| 21 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.61887420 |
| 22 | Hepatocellular necrosis (HP:0001404) | 3.59814274 |
| 23 | Hepatic necrosis (HP:0002605) | 3.55489623 |
| 24 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.53458455 |
| 25 | Hypoglycemic seizures (HP:0002173) | 3.51298878 |
| 26 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.48056884 |
| 27 | Hypobetalipoproteinemia (HP:0003563) | 3.45243074 |
| 28 | Hyperammonemia (HP:0001987) | 3.44974765 |
| 29 | Symptomatic seizures (HP:0011145) | 3.34071513 |
| 30 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.31597402 |
| 31 | Abnormality of the common coagulation pathway (HP:0010990) | 3.29270923 |
| 32 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.28372785 |
| 33 | Hyperuricemia (HP:0002149) | 3.28250203 |
| 34 | Increased purine levels (HP:0004368) | 3.28250203 |
| 35 | B lymphocytopenia (HP:0010976) | 3.24269580 |
| 36 | Mitochondrial inheritance (HP:0001427) | 3.19191069 |
| 37 | Acute necrotizing encephalopathy (HP:0006965) | 3.18250998 |
| 38 | Abnormality of B cell number (HP:0010975) | 3.16300271 |
| 39 | Abnormality of nucleobase metabolism (HP:0010932) | 3.13425486 |
| 40 | Abnormality of serum amino acid levels (HP:0003112) | 3.13136352 |
| 41 | Joint hemorrhage (HP:0005261) | 3.11191365 |
| 42 | Abnormality of methionine metabolism (HP:0010901) | 3.10396941 |
| 43 | Abnormality of the intrinsic pathway (HP:0010989) | 3.09716486 |
| 44 | Increased CSF lactate (HP:0002490) | 3.08013960 |
| 45 | Fat malabsorption (HP:0002630) | 3.07495112 |
| 46 | Complement deficiency (HP:0004431) | 3.06882205 |
| 47 | Acute encephalopathy (HP:0006846) | 3.02158165 |
| 48 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.96440307 |
| 49 | Dicarboxylic aciduria (HP:0003215) | 2.96440307 |
| 50 | Palpitations (HP:0001962) | 2.93894388 |
| 51 | Abnormality of proline metabolism (HP:0010907) | 2.91769975 |
| 52 | Hydroxyprolinuria (HP:0003080) | 2.91769975 |
| 53 | Hyperglycemia (HP:0003074) | 2.91375619 |
| 54 | Hypolipoproteinemia (HP:0010981) | 2.90107337 |
| 55 | Increased serum pyruvate (HP:0003542) | 2.89914521 |
| 56 | Hypoalphalipoproteinemia (HP:0003233) | 2.85015254 |
| 57 | Progressive macrocephaly (HP:0004481) | 2.80658886 |
| 58 | Proximal tubulopathy (HP:0000114) | 2.80156889 |
| 59 | Epidermoid cyst (HP:0200040) | 2.79890229 |
| 60 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.79569112 |
| 61 | Increased circulating renin level (HP:0000848) | 2.79205692 |
| 62 | Increased intramyocellular lipid droplets (HP:0012240) | 2.73541572 |
| 63 | Increased muscle lipid content (HP:0009058) | 2.72081596 |
| 64 | Alkalosis (HP:0001948) | 2.70840983 |
| 65 | Hyperactive renin-angiotensin system (HP:0000841) | 2.70743616 |
| 66 | Lactic acidosis (HP:0003128) | 2.67512574 |
| 67 | Metabolic acidosis (HP:0001942) | 2.64373559 |
| 68 | Acute hepatic failure (HP:0006554) | 2.64170004 |
| 69 | Hypokalemic alkalosis (HP:0001949) | 2.63261158 |
| 70 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.62912607 |
| 71 | Aplastic anemia (HP:0001915) | 2.62879318 |
| 72 | Abnormality of glycolysis (HP:0004366) | 2.61387997 |
| 73 | Abnormality of vitamin B metabolism (HP:0004340) | 2.61160305 |
| 74 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.58620598 |
| 75 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.58620598 |
| 76 | Irritability (HP:0000737) | 2.55349342 |
| 77 | Lethargy (HP:0001254) | 2.55284473 |
| 78 | Hyperbilirubinemia (HP:0002904) | 2.55238070 |
| 79 | Rhabdomyolysis (HP:0003201) | 2.51885649 |
| 80 | Abnormality of urine glucose concentration (HP:0011016) | 2.47749204 |
| 81 | Glycosuria (HP:0003076) | 2.47749204 |
| 82 | Increased serum lactate (HP:0002151) | 2.46090549 |
| 83 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.43989968 |
| 84 | Methylmalonic acidemia (HP:0002912) | 2.43437550 |
| 85 | Ragged-red muscle fibers (HP:0003200) | 2.43424598 |
| 86 | Respiratory failure (HP:0002878) | 2.37294275 |
| 87 | Myocardial infarction (HP:0001658) | 2.37168622 |
| 88 | Methylmalonic aciduria (HP:0012120) | 2.36901628 |
| 89 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.35895494 |
| 90 | Confusion (HP:0001289) | 2.34062618 |
| 91 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.32924237 |
| 92 | Late onset (HP:0003584) | 2.32877522 |
| 93 | Delayed CNS myelination (HP:0002188) | 2.32838931 |
| 94 | CNS demyelination (HP:0007305) | 2.31967658 |
| 95 | Vascular calcification (HP:0004934) | 2.28880937 |
| 96 | Polyuria (HP:0000103) | 2.25381570 |
| 97 | Abnormality of complement system (HP:0005339) | 2.24181432 |
| 98 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.23784128 |
| 99 | Elevated alkaline phosphatase (HP:0003155) | 2.22932052 |
| 100 | Abnormal urine output (HP:0012590) | 2.21074084 |
| 101 | Steatorrhea (HP:0002570) | 2.20765657 |
| 102 | Petechiae (HP:0000967) | 2.20185394 |
| 103 | Rickets (HP:0002748) | 2.20064081 |
| 104 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.19140511 |
| 105 | Metabolic alkalosis (HP:0200114) | 2.18298733 |
| 106 | Skin nodule (HP:0200036) | 2.17528676 |
| 107 | Pancreatitis (HP:0001733) | 2.16187850 |
| 108 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.15470913 |
| 109 | Lipid accumulation in hepatocytes (HP:0006561) | 2.14932445 |
| 110 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.13675854 |
| 111 | Abnormality of chloride homeostasis (HP:0011422) | 2.12758848 |
| 112 | Hypophosphatemia (HP:0002148) | 2.12746379 |
| 113 | Chronic diarrhea (HP:0002028) | 2.12367295 |
| 114 | Vacuolated lymphocytes (HP:0001922) | 2.09913277 |
| 115 | Abnormality of the prostate (HP:0008775) | 2.09540863 |
| 116 | Hypomagnesemia (HP:0002917) | 2.08448158 |
| 117 | Vomiting (HP:0002013) | 2.07963913 |
| 118 | Stomatitis (HP:0010280) | 2.07608298 |
| 119 | IgM deficiency (HP:0002850) | 2.07546951 |
| 120 | Sensorimotor neuropathy (HP:0007141) | 2.07087372 |
| 121 | Hypercholesterolemia (HP:0003124) | 2.06661325 |
| 122 | Abnormal protein glycosylation (HP:0012346) | 2.06465003 |
| 123 | Abnormal glycosylation (HP:0012345) | 2.06465003 |
| 124 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.06465003 |
| 125 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.06465003 |
| 126 | Axonal loss (HP:0003447) | 2.04699558 |
| 127 | Systemic lupus erythematosus (HP:0002725) | 2.00943108 |
| 128 | Type I transferrin isoform profile (HP:0003642) | 2.00092534 |
| 129 | Protuberant abdomen (HP:0001538) | 1.98435869 |
| 130 | Severe combined immunodeficiency (HP:0004430) | 1.98275156 |
| 131 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.97885256 |
| 132 | Abnormality of alanine metabolism (HP:0010916) | 1.97885256 |
| 133 | Hyperalaninemia (HP:0003348) | 1.97885256 |
| 134 | Cerebral palsy (HP:0100021) | 1.97610335 |
| 135 | Cerebral edema (HP:0002181) | 1.97583016 |
| 136 | Abnormality of vitamin metabolism (HP:0100508) | 1.97486795 |
| 137 | Hypothermia (HP:0002045) | 1.97240326 |
| 138 | Neoplasm of the adrenal gland (HP:0100631) | 1.96480581 |
| 139 | Cardiovascular calcification (HP:0011915) | 1.96250217 |
| 140 | Exercise intolerance (HP:0003546) | 1.95442696 |
| 141 | Abnormality of renal excretion (HP:0011036) | 1.94935016 |
| 142 | Polydipsia (HP:0001959) | 1.94628309 |
| 143 | Abnormal drinking behavior (HP:0030082) | 1.94628309 |
| 144 | Emotional lability (HP:0000712) | 1.93679211 |
| 145 | Recurrent abscess formation (HP:0002722) | 1.93125349 |
| 146 | Progressive neurologic deterioration (HP:0002344) | 1.92984339 |
| 147 | Opisthotonus (HP:0002179) | 1.92893409 |
| 148 | Mitral stenosis (HP:0001718) | 1.90800772 |
| 149 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.89576286 |
| 150 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.89576286 |
| 151 | Abnormality of renin-angiotensin system (HP:0000847) | 1.89257518 |
| 152 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.89130145 |
| 153 | Abnormality of magnesium homeostasis (HP:0004921) | 1.89035532 |
| 154 | Renal Fanconi syndrome (HP:0001994) | 1.88114678 |
| 155 | Tetany (HP:0001281) | 1.86183914 |
| 156 | Reduced antithrombin III activity (HP:0001976) | 1.86082596 |
| 157 | Nausea (HP:0002018) | 1.83934696 |
| 158 | Megaloblastic anemia (HP:0001889) | 1.83714501 |
| 159 | Limb hypertonia (HP:0002509) | 1.82003461 |
| 160 | Tetraplegia (HP:0002445) | 1.80766183 |
| 161 | Abnormal pupillary function (HP:0007686) | 1.80721212 |
| 162 | Albinism (HP:0001022) | 1.80101253 |
| 163 | Abnormality of iron homeostasis (HP:0011031) | 1.79865467 |
| 164 | Increased hepatocellular lipid droplets (HP:0006565) | 1.78831323 |
| 165 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.78378448 |
| 166 | Cerebral hypomyelination (HP:0006808) | 1.71753301 |
| 167 | Elevated hepatic transaminases (HP:0002910) | 1.70667900 |
| 168 | Multiple enchondromatosis (HP:0005701) | 1.70466573 |
| 169 | 3-Methylglutaconic aciduria (HP:0003535) | 1.70186837 |
| 170 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.67373672 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.81249108 |
| 2 | MST4 | 4.06591669 |
| 3 | WNK3 | 3.67406751 |
| 4 | VRK2 | 3.64686179 |
| 5 | TAOK3 | 3.58206846 |
| 6 | INSRR | 3.51030863 |
| 7 | WNK4 | 3.18290488 |
| 8 | IRAK3 | 3.11694939 |
| 9 | OXSR1 | 3.01489717 |
| 10 | MAP3K12 | 2.75259128 |
| 11 | MAPK15 | 2.66190141 |
| 12 | PINK1 | 2.60656020 |
| 13 | FLT3 | 2.48106001 |
| 14 | AKT3 | 2.31780822 |
| 15 | PIK3CG | 2.27075407 |
| 16 | SIK1 | 2.23447847 |
| 17 | FGFR4 | 2.09054228 |
| 18 | NEK1 | 2.00332902 |
| 19 | NUAK1 | 1.94952115 |
| 20 | MAP3K14 | 1.83687449 |
| 21 | CAMKK2 | 1.83164612 |
| 22 | SCYL2 | 1.82903759 |
| 23 | EPHA2 | 1.80759017 |
| 24 | BMPR2 | 1.77123474 |
| 25 | ZAK | 1.75514587 |
| 26 | DAPK1 | 1.70324440 |
| 27 | TAF1 | 1.65531220 |
| 28 | MAP4K1 | 1.60931747 |
| 29 | EIF2AK1 | 1.60177430 |
| 30 | ERBB4 | 1.59198176 |
| 31 | BMPR1B | 1.58015101 |
| 32 | FRK | 1.56439940 |
| 33 | TEC | 1.55797759 |
| 34 | MAP4K2 | 1.54378736 |
| 35 | TRIM28 | 1.53795201 |
| 36 | TESK1 | 1.52903400 |
| 37 | MAP2K4 | 1.52378505 |
| 38 | PDK2 | 1.50591360 |
| 39 | TSSK6 | 1.48312264 |
| 40 | TESK2 | 1.45188487 |
| 41 | MAP2K7 | 1.44781341 |
| 42 | STK38L | 1.43583682 |
| 43 | TNIK | 1.37673493 |
| 44 | ACVR1B | 1.33009415 |
| 45 | BUB1 | 1.32023777 |
| 46 | MET | 1.28263111 |
| 47 | MST1R | 1.25437122 |
| 48 | CSNK1G1 | 1.23421307 |
| 49 | ERBB3 | 1.22539219 |
| 50 | SRPK1 | 1.20789183 |
| 51 | KDR | 1.20717132 |
| 52 | CSNK1G3 | 1.20125650 |
| 53 | MAP3K3 | 1.16657474 |
| 54 | IKBKE | 1.15358575 |
| 55 | MAP3K2 | 1.13417546 |
| 56 | MAP3K4 | 1.10306377 |
| 57 | PIM2 | 1.09694170 |
| 58 | ABL2 | 1.03732988 |
| 59 | EIF2AK3 | 1.03234978 |
| 60 | SYK | 1.01907354 |
| 61 | PRKAA2 | 1.01426085 |
| 62 | IRAK2 | 0.99711674 |
| 63 | VRK1 | 0.98525072 |
| 64 | CCNB1 | 0.96758606 |
| 65 | MAP3K11 | 0.95221985 |
| 66 | NEK6 | 0.94739637 |
| 67 | SGK494 | 0.93327680 |
| 68 | SGK223 | 0.93327680 |
| 69 | LIMK1 | 0.91969585 |
| 70 | DAPK2 | 0.91790678 |
| 71 | TYK2 | 0.90898326 |
| 72 | STK16 | 0.89651608 |
| 73 | ERN1 | 0.89603573 |
| 74 | STK39 | 0.88871945 |
| 75 | PLK3 | 0.87632923 |
| 76 | MAP3K13 | 0.87382358 |
| 77 | TBK1 | 0.87301997 |
| 78 | PRKAA1 | 0.86641071 |
| 79 | EIF2AK2 | 0.86612320 |
| 80 | CSF1R | 0.85806017 |
| 81 | MAPK11 | 0.84204242 |
| 82 | RAF1 | 0.83746797 |
| 83 | STK38 | 0.79222614 |
| 84 | FER | 0.77644652 |
| 85 | ZAP70 | 0.75647213 |
| 86 | JAK2 | 0.75282050 |
| 87 | OBSCN | 0.75121869 |
| 88 | PTK2 | 0.74172723 |
| 89 | TNK2 | 0.74136632 |
| 90 | EPHA4 | 0.72893862 |
| 91 | NLK | 0.72157811 |
| 92 | BTK | 0.71815979 |
| 93 | CAMK2G | 0.71768998 |
| 94 | MUSK | 0.70068164 |
| 95 | PRKCI | 0.68865897 |
| 96 | PDK4 | 0.68029774 |
| 97 | PDK3 | 0.68029774 |
| 98 | LYN | 0.66063056 |
| 99 | GRK1 | 0.65506737 |
| 100 | CDK3 | 0.65103809 |
| 101 | LATS1 | 0.64359078 |
| 102 | JAK1 | 0.63741177 |
| 103 | SGK2 | 0.62560022 |
| 104 | SGK3 | 0.61547406 |
| 105 | WNK1 | 0.61090377 |
| 106 | MAP3K5 | 0.60771264 |
| 107 | BRSK2 | 0.58427842 |
| 108 | IRAK1 | 0.58379062 |
| 109 | KIT | 0.57136520 |
| 110 | NME2 | 0.56958815 |
| 111 | PRKCH | 0.55737940 |
| 112 | MAP3K7 | 0.55075479 |
| 113 | PBK | 0.54424804 |
| 114 | PLK1 | 0.54031122 |
| 115 | PDPK1 | 0.54004248 |
| 116 | CAMKK1 | 0.53993565 |
| 117 | TTN | 0.53749228 |
| 118 | PRKCQ | 0.53168892 |
| 119 | TXK | 0.52916136 |
| 120 | GRK7 | 0.52572062 |
| 121 | BCR | 0.51549838 |
| 122 | FGR | 0.51167037 |
| 123 | MATK | 0.51154664 |
| 124 | TIE1 | 0.50925418 |
| 125 | DYRK2 | 0.50616994 |
| 126 | PRKACG | 0.50466833 |
| 127 | RIPK4 | 0.50465888 |
| 128 | EPHA3 | 0.50316506 |
| 129 | MAPK7 | 0.49840071 |
| 130 | PTK6 | 0.49273876 |
| 131 | IGF1R | 0.49125499 |
| 132 | LCK | 0.47892788 |
| 133 | NTRK3 | 0.47696825 |
| 134 | SIK3 | 0.47107532 |
| 135 | MYLK | 0.45929611 |
| 136 | FES | 0.44676471 |
| 137 | NEK9 | 0.44551270 |
| 138 | ADRBK2 | 0.44523607 |
| 139 | ALK | 0.44358148 |
| 140 | BMX | 0.43579101 |
| 141 | PAK3 | 0.43558169 |
| 142 | STK10 | 0.43408303 |
| 143 | SGK1 | 0.42036767 |
| 144 | BLK | 0.41920706 |
| 145 | JAK3 | 0.41495948 |
| 146 | CLK1 | 0.41237844 |
| 147 | CSNK1A1L | 0.40283099 |
| 148 | CAMK2D | 0.40158155 |
| 149 | ATR | 0.40095558 |
| 150 | PKN1 | 0.39837566 |
| 151 | GSK3A | 0.39361557 |
| 152 | MINK1 | 0.38983445 |
| 153 | NME1 | 0.38648629 |
| 154 | CAMK2B | 0.38490621 |
| 155 | ITK | 0.38159275 |
| 156 | CDK6 | 0.38107001 |
| 157 | MAP3K1 | 0.37781179 |
| 158 | PRKCG | 0.37637608 |
| 159 | CAMK1D | 0.37586153 |
| 160 | AURKB | 0.37213058 |
| 161 | ABL1 | 0.35646747 |
| 162 | ARAF | 0.34931843 |
| 163 | CSK | 0.33261701 |
| 164 | PKN2 | 0.33149839 |
| 165 | IKBKB | 0.32464967 |
| 166 | PRKCE | 0.32091577 |
| 167 | BRD4 | 0.31156795 |
| 168 | CSNK1A1 | 0.31146357 |
| 169 | PRKCA | 0.30061263 |
| 170 | CSNK1G2 | 0.30033311 |
| 171 | SIK2 | 0.29481165 |
| 172 | EPHB1 | 0.24582820 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 3.43567201 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.32749918 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.96210287 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.92907272 |
| 5 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.86628063 |
| 6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.84084948 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.74546193 |
| 8 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.73902070 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.67863628 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.48942407 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.48366440 |
| 12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.44531905 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.41721479 |
| 14 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.28147049 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.12018486 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.09080608 |
| 17 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.94716537 |
| 18 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.94373566 |
| 19 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.90082593 |
| 20 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.89802573 |
| 21 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.85443999 |
| 22 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.78000136 |
| 23 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.77886119 |
| 24 | Asthma_Homo sapiens_hsa05310 | 1.77823280 |
| 25 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.75596488 |
| 26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.74299098 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.73254233 |
| 28 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.72947851 |
| 29 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.66953796 |
| 30 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.66649810 |
| 31 | Histidine metabolism_Homo sapiens_hsa00340 | 1.66110364 |
| 32 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.65989413 |
| 33 | Allograft rejection_Homo sapiens_hsa05330 | 1.65815977 |
| 34 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.64312786 |
| 35 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.62843686 |
| 36 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.59589267 |
| 37 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.56732677 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.56098722 |
| 39 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.55178960 |
| 40 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.44417866 |
| 41 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.44412172 |
| 42 | Parkinsons disease_Homo sapiens_hsa05012 | 1.42859148 |
| 43 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.39352510 |
| 44 | Bile secretion_Homo sapiens_hsa04976 | 1.37971752 |
| 45 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.37260882 |
| 46 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.35021503 |
| 47 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.34063956 |
| 48 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.33748624 |
| 49 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.33225113 |
| 50 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.32758552 |
| 51 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.29665238 |
| 52 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.28284780 |
| 53 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.28081818 |
| 54 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.26903150 |
| 55 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.25468113 |
| 56 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.23984540 |
| 57 | Carbon metabolism_Homo sapiens_hsa01200 | 1.23438192 |
| 58 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.19641645 |
| 59 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.17305444 |
| 60 | Mismatch repair_Homo sapiens_hsa03430 | 1.16663277 |
| 61 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.16489552 |
| 62 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.14969695 |
| 63 | Retinol metabolism_Homo sapiens_hsa00830 | 1.14190784 |
| 64 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.13038781 |
| 65 | ABC transporters_Homo sapiens_hsa02010 | 1.10854782 |
| 66 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.10849166 |
| 67 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.10812904 |
| 68 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.09400493 |
| 69 | Base excision repair_Homo sapiens_hsa03410 | 1.07636844 |
| 70 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.04829890 |
| 71 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.03421543 |
| 72 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.00210179 |
| 73 | DNA replication_Homo sapiens_hsa03030 | 0.98598783 |
| 74 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.94156562 |
| 75 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.93674020 |
| 76 | Homologous recombination_Homo sapiens_hsa03440 | 0.84325978 |
| 77 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.81130029 |
| 78 | Lysine degradation_Homo sapiens_hsa00310 | 0.79620176 |
| 79 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.79460000 |
| 80 | RNA polymerase_Homo sapiens_hsa03020 | 0.78124785 |
| 81 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.76351189 |
| 82 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.74297884 |
| 83 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.72693593 |
| 84 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.72678678 |
| 85 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.71361112 |
| 86 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.70159985 |
| 87 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.69080833 |
| 88 | Purine metabolism_Homo sapiens_hsa00230 | 0.68627658 |
| 89 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.68451946 |
| 90 | Viral myocarditis_Homo sapiens_hsa05416 | 0.66902791 |
| 91 | Legionellosis_Homo sapiens_hsa05134 | 0.66723240 |
| 92 | Alzheimers disease_Homo sapiens_hsa05010 | 0.65704758 |
| 93 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.64681205 |
| 94 | Lysosome_Homo sapiens_hsa04142 | 0.64481512 |
| 95 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.62845233 |
| 96 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.61311591 |
| 97 | RNA degradation_Homo sapiens_hsa03018 | 0.61042340 |
| 98 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.60633188 |
| 99 | Huntingtons disease_Homo sapiens_hsa05016 | 0.59268634 |
| 100 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.57746826 |
| 101 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.56808610 |
| 102 | Metabolic pathways_Homo sapiens_hsa01100 | 0.56282164 |
| 103 | Sulfur relay system_Homo sapiens_hsa04122 | 0.56265711 |
| 104 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.55077433 |
| 105 | Basal transcription factors_Homo sapiens_hsa03022 | 0.52687382 |
| 106 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.52178046 |
| 107 | Leishmaniasis_Homo sapiens_hsa05140 | 0.50733384 |
| 108 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.50358966 |
| 109 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.48669184 |
| 110 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.48199712 |
| 111 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.46422125 |
| 112 | Galactose metabolism_Homo sapiens_hsa00052 | 0.40979191 |
| 113 | Insulin resistance_Homo sapiens_hsa04931 | 0.38786139 |
| 114 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.38340530 |
| 115 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.36953598 |
| 116 | Other glycan degradation_Homo sapiens_hsa00511 | 0.30327021 |
| 117 | Protein export_Homo sapiens_hsa03060 | 0.28760404 |
| 118 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.27814236 |
| 119 | Circadian rhythm_Homo sapiens_hsa04710 | 0.25400532 |
| 120 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.21947945 |
| 121 | Prion diseases_Homo sapiens_hsa05020 | 0.21219489 |
| 122 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.20584101 |
| 123 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.15108757 |
| 124 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.14832031 |
| 125 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.13964235 |
| 126 | Insulin secretion_Homo sapiens_hsa04911 | 0.11293512 |
| 127 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.11005233 |
| 128 | Mineral absorption_Homo sapiens_hsa04978 | 0.10998476 |
| 129 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.10524878 |
| 130 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.09627742 |
| 131 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.09303521 |
| 132 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.06891509 |
| 133 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.03945774 |
| 134 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.03013042 |
| 135 | Phagosome_Homo sapiens_hsa04145 | -0.0357981 |
| 136 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | -0.0290848 |
| 137 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0268598 |
| 138 | Linoleic acid metabolism_Homo sapiens_hsa00591 | -0.0097784 |

